Publication:
Surgical Technology International XVII - Gynecology
Article title:
Site-Specific Rectocele Repair with
Dermal Graft Augmentation:
Comparison of
Porcine Dermal Xenograft (Pelvicol®) and Human Dermal Allograft
Order Article:
By e-mail: PDF Format - $69.00
Author(s)
Roger C. Biehl., M.D.
Atlanta Urogynecology Associates,
Atlanta, Georgia, USA
Robert D. Moore, D.O.
Atlanta Urogynecology Associates,
Atlanta, Georgia, USA
John R. Miklos, M.D.
Atlanta Urogynecology Associates,
Atlanta, Georgia, USA
Neeraj Kohli, M.D.
Harvard Medical School,
Boston, Massachusetts, USA
Indu S. Anand, M.D.
Atlanta Urogynecology Associates,
Atlanta, Georgia, USA
T. Fleming Mattox, M.D.
Carolina Continence Center,
Division of Urogynecology,
Greenville, Georgia, USA
Abstract
This study is a retrospective chart review comparing 195 women who underwent rectocele repair with either a porcine dermal xenograft or human allogenic cadaveric dermal graft augmentation over a two year period. A site-specific defect repair was completed prior to augmentation with the graft. Examinations were performed preoperatively and postoperatively using the pelvic organ prolapse quantification system. Questionnaires were used to assess constipation and dyspareunia. De novo dyspareunia and cure rates for constipation and dyspareunia were not statistically different between the two groups. Site-specific fascial rectocele repairs with xenograft or allograft augmentation were found to have similar complication rates as well as objective and subjective cure rates.
Product featured in the Article:
Pelvicol®